Nootropil

Nootropil Adverse Reactions

piracetam

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Full Prescribing Info
Adverse Reactions
Clinical Trial and Post Marketing Data: Double-blind placebo-controlled clinical or pharmaco-clinical trials, of which quantified safety data are available, included more than 3000 subjects receiving Piracetam (Nootropil), regardless of indication, dosage form, daily dosage or population characteristics. Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency.
Frequencies are defined as: Very common ≥1/10, Common ≥1/100 to <1/10, Uncommon ≥1/1000 to <1/100, Rare ≥1/10000 to <1/1000, Very rare <1/10000, Not known (cannot be estimated from the available data) (see Table 2).

Click on icon to see table/diagram/image
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in